I.G. Investment Management’s GSK GSK Stock Holding History

I.G. Investment Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-136,408	Closed	-$6.88M	–	917
2015 Q4	$6.88M	Hold	136,408	–	–	0.03%	295
2015 Q3	$6.56M	Sell	136,408 -27,654	-17%	-$1.44M	0.03%	291
2015 Q2	$8.54M	Hold	164,062	–	–	0.03%	267
2015 Q1	$9.46M	Buy	164,062 +20,436	+14%	+$1.17M	0.04%	252
2014 Q4	$7.67M	Hold	143,626	–	–	0.03%	278
2014 Q3	$8.25M	Sell	143,626 -72,240	-33%	-$4.43M	0.03%	265
2014 Q2	$14.4M	Buy	215,866 +960	+0.4%	+$65K	0.05%	195
2014 Q1	$14.4M	Buy	214,906 +2,480	+1%	+$168K	0.05%	187
2013 Q4	$14.2M	Buy	212,426 +1,200	+0.6%	+$77.8K	0.05%	190
2013 Q3	$13.2M	Buy	211,226 +560	+0.3%	+$36K	0.05%	194
2013 Q2	$13.2M	Buy	+210,666	New	+$13.4M	0.05%	193

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

I.G. Investment Management's GSK Position: Q1 2016 in Review

I.G. Investment Management sold out of GSK (GSK) in Q1 2016, closing a stake of 136,408 shares — an estimated $6.88M sold.

I.G. Investment Management first reported a position in GSK in Q2 2013 and held it in 11 quarters. The position peaked at $14.4M in Q2 2014. 726 funds tracked by Wall St. Rank hold GSK as of Q1 2016.

I.G. Investment Management reported no remaining GSK position as of Q1 2016 after selling out during the quarter.
I.G. Investment Management sold 136,408 GSK shares in Q1 2016, an estimated $6.88M.
I.G. Investment Management first reported a position in GSK in Q2 2013 and held it in 11 quarters.
I.G. Investment Management's GSK position peaked at $14.4M in Q2 2014.
726 funds tracked by Wall St. Rank held GSK as of Q1 2016.

Based on I.G. Investment Management's 13F filing for Q1 2016, filed 13 May 2016.